Heidegger, H.; Dietlmeier, S.; Ye, Y.; Kuhn, C.; Vattai, A.; Aberl, C.; Jeschke, U.; Mahner, S.; Kost, B.
The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients. Int. J. Mol. Sci. 2017, 18, 1571.
https://doi.org/10.3390/ijms18071571
AMA Style
Heidegger H, Dietlmeier S, Ye Y, Kuhn C, Vattai A, Aberl C, Jeschke U, Mahner S, Kost B.
The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients. International Journal of Molecular Sciences. 2017; 18(7):1571.
https://doi.org/10.3390/ijms18071571
Chicago/Turabian Style
Heidegger, Helene, Sebastian Dietlmeier, Yao Ye, Christina Kuhn, Aurelia Vattai, Caroline Aberl, Udo Jeschke, Sven Mahner, and Bernd Kost.
2017. "The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients" International Journal of Molecular Sciences 18, no. 7: 1571.
https://doi.org/10.3390/ijms18071571
APA Style
Heidegger, H., Dietlmeier, S., Ye, Y., Kuhn, C., Vattai, A., Aberl, C., Jeschke, U., Mahner, S., & Kost, B.
(2017). The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients. International Journal of Molecular Sciences, 18(7), 1571.
https://doi.org/10.3390/ijms18071571